Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies

被引:154
作者
El Maghraby, GMM [1 ]
Williams, AC [1 ]
Barry, BW [1 ]
机构
[1] Univ Bradford, Sch Pharm, Postgrad Studies Pharmaceut Technol, Drug Delivery Grp, Bradford BD7 1DP, W Yorkshire, England
关键词
D O I
10.1211/0022357991776813
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Deformable vesicles and traditional liposomes were compared as delivery systems for oestradiol to elucidate possible mechanisms of drug delivery through human skin. Accordingly, epidermal permeation of oestradiol from optimized deformable vesicles and traditional liposome formulations was studied under low dose non-occluded conditions. Five mechanisms were investigated. A free drug mechanism compared low-dose permeation through skin with drug release determined after separation of the free drug. Penetration enhancement was researched by studying skin pretreatment with empty vesicles. Improved drug uptake by skin was monitored by dipping stratum corneum into different formulations for 10 min and determining drug uptake. The possibility that intact vesicles permeate through the epidermis was tested by comparing permeation from 136-nm vesicles with that from > 500-nm vesicles, assuming that penetration depends on vesicle size. The possibility that different entrapment efficiencies in alternative formulations could be responsible for the difference in delivery was also evaluated. Lipid vesicles improved the skin delivery of oestradiol compared with delivery from an aqueous control. Maximum flux (J(max)) was increased 14- to 17-fold by use of deformable vesicles and 8.2- to 9.8-fold by use of traditional liposomes. Deformable vesicles were thus superior to traditional liposomes. Drug release was negligible over the period during which skin flux was maximum. Pretreatment with empty vesicles resulted in an enhancement ratio of 4.3 for pure phosphatidylcholine (PC) vesicles but the enhancement ratio ranged from only 0.8 to 2.4 for other formulations. Vesicles increased drug uptake into the stratum corneum 23- to 29-fold. Relative flux values obtained from small and large vesicles were similar. No correlation was found between entrapment efficiency and skin delivery. The results showed no evidence of a free drug mechanism, but revealed a possible penetration-enhancing effect for pure PC vesicles, although this was not the only mechanism operating. The positive uptake suggested that lipid vesicles increased drug partitioning into the skin. The data provided no evidence for in-vitro liposome penetration through skin as distinct from vesicle penetration into the stratum corneum.
引用
收藏
页码:1123 / 1134
页数:12
相关论文
共 30 条
[1]   AN AUTOMATED DIFFUSION APPARATUS FOR STUDYING SKIN PENETRATION [J].
AKHTER, SA ;
BENNETT, SL ;
WALLER, IL ;
BARRY, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (01) :17-26
[2]  
ARTMANN C, 1990, ARZNEIMITTEL-FORSCH, V40-2, P1365
[3]  
ARTMANN C, 1990, ARZNEIMITTEL-FORSCH, V40-2, P1363
[4]  
Barry, 1983, DERMATOLOGICAL FORMU
[5]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[6]   Percutaneous absorption of a new antiandrogen included in liposomes or in solution [J].
Bernard, E ;
Dubois, JL ;
Wepierre, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :235-243
[7]   LIPID VESICLES PENETRATE INTO INTACT SKIN OWING TO THE TRANSDERMAL OSMOTIC GRADIENTS AND HYDRATION FORCE [J].
CEVC, G ;
BLUME, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1104 (01) :226-232
[8]   The skin: A pathway for systemic treatment with patches and lipid-based agent carriers [J].
Cevc, G ;
Blume, G ;
Schatzlein, A ;
Gebauer, D ;
Paul, A .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 18 (03) :349-378
[9]   TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES [J].
CEVC, G ;
SCHATZLEIN, A ;
BLUME, G .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :3-16
[10]   Percutaneous penetration of liposomes using the tape stripping technique [J].
Coderch, L ;
Oliva, M ;
Pons, M ;
delaMaza, A ;
Manich, AM ;
Parra, JL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 139 (1-2) :197-203